Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients with Generalized Myasthenia Gravis

Investigator site 10 - HU0360013, Budapest

Investigator site 9 - HU0360012, Budapest

Investigator site 16 - NL0310001, Leiden

Investigator site 5 - BE0320007, Ghent

Investigator Site 25 - DE490006, Berlin

Investigator Site 46 - US0010111, Amherst

Investigator site 11 - IT0390003, Milan

Investigator Site 38 - US0010003, Chapel Hill

Investigator Site 44 - US0010077, Durham

Investigator Site 45 - US0010108, Boca Raton

Investigator site 4 - US0010110, Port Charlotte

Investigator site 7 - US0010008, Cordova

Investigator Site 39 - US0010006, Tampa

Investigator Site 42 - US0010019, Cleveland

Investigator site 23 - ES0340039, Valencia

Investigator Site 26 - DE490009, Münster

Investigator Site 41 - US0010015, Kansas City

Investigator Site 40 - US0010009, San Antonio

Investigator Site 43 - US0010066, Austin

Investigator Site 34 - IT0390007, Napoli

Investigator site 6 - US0010032, Carlsbad

Investigator Site 47 - US0010021, Palo Alto

Investigator Site 30 - RU0070014, Saint Petersburg

Investigator Site 29- RU0070002, Novosibirsk

Investigator site 24 - CZ4200005, Brno

Investigator Site 32 - GEO9950004, Tbilisi

Investigator Site 33 - GEO9950016, Tbilisi

Investigator site 2 - GEO9950002, Tbilisi

Investigator Site 1 - GEO9950001, Tbilisi

Investigator site 3 - GEO9950003, Tbilisi

Investigator Site 35 - IT0390008, Roma

Investigator site 12 - JP0810002, Chiba

Investigator Site 36 - JP0810055, Sapporo

Investigator site 8 - JP0810004, Hanamaki

Investigator Site 28- JP0810059, Ōta-ku

Investigator site 14 - JP0810007, Osaka

Investigator Site 27 - JP0810008, Sapporo

Investigator site 13 - JP0810005, Sendai

Investigator site 15 - JP0810009, Tokyo

Investigator site 17 - PL0480001, Gdansk

Investigator site 19 - PL0480007, Katowice

Investigator site 22 - PL0480065, Krakow

Investigator site 18 - PL0480005, Krakow

Investigator site 20 - PL0480018, Lublin

Investigator site 21 - PL0480022, Warsaw

Investigator Site 37 - ES0340021, Barcelona

Investigator Site 31 - ES0340038, Barcelona